Humacyte prices $50M public offering of 47.6M shares at $1.05 per share

Humacyte, Inc.

Sold 47,619,048 shares at $1.05/share; gross proceeds ~$50M.
Net proceeds expected ~$46.8M (~$53.85M if underwriters exercise 30-day over-allotment of 7,142,857 shares).
Proceeds to fund Symvess commercialization, BLA supplement for hemodialysis, pipeline development, and working capital.
Offering expected to close June 12, 2026; joint book-runners: Barclays, BTIG, Titan Partners.
30-day underwriter option for additional 15% of shares at same price.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.98

Humacyte, Inc. entered into Underwriting Agreement with Barclays Capital Inc., BTIG, LLC and Titan Partners Group LLC, a division of American Capital Partners, LLC, as representatives of the several underwriters named therein valued at approximately $46.80 million (effective 2026-06-10).

Action: entry
Agreement: underwriting
Counterparty: Barclays Capital Inc., BTIG, LLC and Titan Partners Group LLC, a division of American Capital Partners, LLC, as representatives of the several underwriters named therein
Value: approximately $46.80 million
Effective: 2026-06-10

Exact text from the filing

On June 10 , 2026, Humacyte, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc., BTIG, LLC and Titan Partners Group LLC, a division of American Capital Partners, LLC, as representatives of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale in an underwritten offering (the “Offering”), pursuant to which the Company agreed to issue and sell 47,619,048 shares of the Company’s common stock, $0.0001 par value per share, at a price to the public of $1.05 per share (the “Firm Shares”).

View on SEC.gov

802 material agreements filed in the last 30 days. Browse all material agreements →

Humacyte, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-072980

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.